Enlivex
Dr. Mothy serves as Professor of Hematology and head of the Hematology and Cellular Therapy Department at the Saint-Antoine Hospital and University Pierre & Marie Curie (Paris, France). Dr. Mohty is also President of the European Society for Blood and Marrow Transplantation (EBMT).
Dr. Mohty is also head of a translational research team (INSERM) at the Saint-Antoine Research centre in Paris and his research is focused on the pathophysiology and immunobiology of normal and pathological antigen-presenting cells, especially the impact of immunomodulatory agents.
He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of multiple myeloma. He also serves on the board of the EBMT, and the “Intergroupe Francophone du Myelome” (IFM).
This person is not in the org chart
This person is not in any offices
Enlivex
Enlivex's mission is to establish new equilibriums – both in patients’ immune responses and in the field of immunotherapy. As a clinical-stage company focused on specialized cell immunotherapy, Enlivex intends to develop and commercialize an allogeneic drug pipeline for rebalancing all manner of immune hyper-responses.